Cephalosporin Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC530

Introduction

Cephalosporins are one of the largest and most diverse family of antibiotics of the bactericidal β-lactam group. Based on their antimicrobial activity, they are grouped into various type of generations. Cephalosporin inhibits enzymes in the cell wall of susceptible bacteria, hence disrupting cell synthesis. Increasing research and development activities, and increasing demand for antibacterial drugs is propelling the growth of cephalosporin market.

Market Dynamics

The market for cephalosporin would continue to rise immensely with the aging population and increasing incidences of infectious diseases worldwide. Cephalosporin have a broad range of therapeutic application and are effective in the treatment of streptococcal, pneumococcal, staphylococcal, Klebsiella, Escherichia coli and Proteus infections. One of the significant roles of cephalosporin has been as chemoprophylactic agents at the time of surgical procedures. In addition, cephalosporin has the ability to retain excellent pharmacokinetic properties, hence making cephalosporin drugs as the first choice for treatment of various infections. However, factors such as certain side-effects associated with cephalosporin and development of drug-resistant bacterial strains might restrain the growth of cephalosporin market.

Market Classification and Overview

The cephalosporin market is segmented on the basis of generation, route of administration, type, application and geography. Based on route of administration, the market is segmented into oral and injection. The injection route of administration is anticipated to grow swiftly during the forecast period owing to its ease-of-use, and better patient compliance.

Based on application, the global market has been bifurcated into sexually transmitted infection, respiratory tract infection, skin infection, ear infection, and urinary tract infection. Sexually transmitted infection dominated the application segment in 2016. Factors such as increasing number of people suffering from sexually transmitted diseases, and excellent efficacy of cephalosporin as antibiotics are driving the market growth. According to the WHO, more than 1 million sexually transmitted infections are acquired each day worldwide.

Regional Overview

Regionally, the market for cephalosporin is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). North America is dominating the global market owing to the presence of highly advanced healthcare facilities, and presence of large number of patient population affected with sexually transmitted diseases. However, Asia-Pacific is expected to grow at the fastest CAGR due to increased population base, growing disposable income in countries like China and India, and beneficial government initiatives.

Report Coverage

Market

Cephalosporin Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Generation, Route of Administration, Type, Application, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

F. Hoffmann-La Roche Ltd., Lupin Limited, Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, Allergan Plc, GlaxoSmithKline Plc, Merck & Co., Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. are the key players in the cephalosporin market. These players have undertaken mergers and acquisitions as one of their key strategies in order to maximize their share in the global market.

Market Segmentation

Market By Generation

·         First Generation

·         Second Generation

·         Third Generation

·         Fourth Generation

·         Fifth Generation

Market By Route of Administration

·         Oral

·         Injection

Market By Type

·         Branded

·         Generic

Market By Application

·         Sexually Transmitted Infection

·         Respiratory Tract Infection

·         Skin Infection

·         Ear Infection

·         Urinary Tract Infection

Market By Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·         Latin America

o   Brazil

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary